Neurology
ANAVEX2-73 shows encouraging clinical signs for PDD
Anavex has announced preliminary findings from an extended study of its experimental drug ANAVEX2-73 in patients with Parkinson’s Disease Dementia (PDD).
Anavex has announced preliminary findings from an extended study of its experimental drug ANAVEX2-73 in patients with Parkinson’s Disease Dementia (PDD).